US Broker Ratings

PROCEPT BioRobotics (PRCT) Stock Analysis: Exploring a 34.75% Potential Upside with Innovative Medical Devices

For investors seeking to diversify their portfolios within the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a compelling opportunity, particularly with its robust growth potential and innovative product line..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Unpacking a 40% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out in the biotechnology sector with its focus on developing therapies for rare and neurological diseases. With a market capitalization of $2.02 billion,..

Certara, Inc. (CERT) Stock Analysis: Potential 55.60% Upside Lures Investors

Certara, Inc. (NASDAQ: CERT) stands as a significant player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.65 billion, Certara has carved..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 95% Potential Upside

NovoCure Limited (NASDAQ: NVCR) stands at an intriguing juncture, presenting a unique opportunity for investors with a notable potential upside of 95.65%. As a pioneering player in the healthcare sector,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unleashing Nearly 100% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnological innovator headquartered in Durham, North Carolina, is making waves in the healthcare sector, particularly in the niche realm of rare disease therapeutics. With..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech with 140% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE) has captured the attention of investors with its promising pipeline in the biotechnology sector. With a market capitalization of $2.28 billion, this clinical-stage biotech company..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Through Recent Market Trends

Envista Holdings Corporation (NYSE: NVST), a notable player in the healthcare sector, specializes in developing and marketing dental products across the globe. With a market capitalization of $3.3 billion, Envista..

Haemonetics Corporation (HAE) Stock Analysis: Uncovering a 23% Upside Potential Amidst Strong Buy Ratings

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative suite of hospital technologies. Headquartered in Boston, Massachusetts,..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Uncovering a 20.78% Upside Potential in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector with its innovative approach to targeting protein growth factors. As a biopharmaceutical company, Scholar Rock is at..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 40% Potential Upside Beckons Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector specializing in medical care facilities, presents an intriguing investment opportunity for those considering the dynamic landscape of non-emergency..

Concentra Group Holdings (CON) Stock Analysis: Exploring a 40% Upside Potential

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector, specifically within the medical care facilities industry, presents an intriguing opportunity for investors seeking exposure to the..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 41% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, stands out with its robust portfolio of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 32% Potential Upside in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) is carving out a significant niche in the dynamic healthcare sector, specifically within the diagnostics and research industry. As a genomics company, GeneDx is at..

Kiniksa Pharmaceuticals (KNSA) Investor Outlook: Eyeing a 43.68% Upside with Strong Buy Ratings

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is generating buzz among investors with its significant growth potential and strong analyst support. Operating in the healthcare sector, specifically within the specialty and generic..

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a Potential 325% Upside

Investors eyeing the healthcare sector might find ImmunityBio, Inc. (NASDAQ: IBRX) an intriguing opportunity, particularly given the biotech company’s notable potential upside of 325.37%. Based in San Diego, California, ImmunityBio..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Biotech with 161% Potential Upside

Amicus Therapeutics, Inc. (FOLD), a key player in the biotechnology industry, is capturing investor attention with its impressive potential upside and innovative approach to treating rare diseases. Headquartered in Princeton,..

Belite Bio, Inc (BLTE) Stock Analysis: Biotech Innovator with 38.66% Upside Potential

Belite Bio, Inc (BLTE) is making waves in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $1.99 billion, the company is positioned as a promising..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 240% Upside Potential for Investors

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a key player in the biotechnology sector, stands out with its focus on developing treatments for rare and ultra-rare genetic diseases. With a market capitalization..

ICU Medical Inc. (ICUI) Stock Analysis: Exploring a Potential 53% Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a significant player in the healthcare sector, offers a diverse range of medical devices that are crucial for infusion therapy, vascular access, and vital care...

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring an 84.81% Potential Upside for Investors

Ardent Health, Inc. (ARDT), a key player in the medical care facilities sector, offers an intriguing investment opportunity with a notable 84.81% potential upside based on analyst assessments. As a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds